CIK 0001430306
- Non-accelerated filer
- Smaller reporting company
Tonix Pharmaceuticals Holding Corp.
Sign in to watch- Ticker
- TNXP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 261434750
- Phone
- +1 212-980-9155
- Business address
- 200 CONNELL DRIVE, SUITE 3100, BERKELEY HEIGHTS, NJ, 07922
- Former names
- TAMANDARE EXPLORATIONS INC.
- 4 Open-market buy Chief Executive Officer bought 6,000 shares at $7.50 ($45,000)
- 4 Open-market buy Director bought 25,000 shares at $7.50 ($187,500)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $7.50 ($7,500)
- 4 Open-market buy Director bought 10,000 shares at $7.50 ($75,000)
- 4 Open-market buy Director bought 6,000 shares at $7.50 ($45,000)
- 4 Open-market buy Chief Medical Officer bought 4,500 shares at $8.38 ($37,710)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $7.02 ($14,033)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $7.24 ($14,470)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.95 ($13,900)
- 4 Open-market buy Director bought 1,000 shares at $6.80 ($6,800)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.48 ($12,950)
- 4 Open-market buy Director bought 4,000 shares at $6.57 ($26,280)
- 4 Open-market buy Chief Executive Officer bought 2,000 shares at an average $6.27 ($12,530)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 14 of 19 · 376 filings